Antonio Delgado Selected Research

(2R,3Z)- N- (1- hydroxyoctadec- 3- en- 2- yl)pivalamide

6/2012	C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
7/2011	Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Delgado Research Topics

Disease

7	Neoplasms (Cancer) 06/2022 - 11/2011
6	Gaucher Disease (Gaucher's Disease) 05/2017 - 07/2007
2	Adenocarcinoma of Lung 06/2022 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 06/2013
2	Carcinogenesis 05/2016 - 05/2013
2	Prostatic Neoplasms (Prostate Cancer) 05/2013 - 07/2011
2	Myocardial Infarction 01/2007 - 01/2005
2	Pathologic Constriction (Stenosis) 09/2004 - 03/2003
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Hypoxia (Hypoxemia) 01/2019
1	Inflammation (Inflammations) 05/2016
1	Multiple Sclerosis 01/2016
1	Neoplasm Metastasis (Metastasis) 05/2013
1	Breast Neoplasms (Breast Cancer) 06/2012
1	Hematologic Neoplasms (Hematological Malignancy) 11/2011
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 03/2011
1	Schizophrenia (Dementia Praecox) 03/2011
1	Iron Deficiencies 10/2010
1	Hypochromic Anemia (Chlorosis) 10/2010
1	Vomiting 02/2006
1	Nausea 02/2006
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2006
1	Congenital Abnormalities (Deformity) 11/2005
1	Mesenteric Ischemia 01/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2005
1	Thrombosis (Thrombus) 01/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2004
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2004
1	Migraine Disorders (Migraine) 01/2004
1	Atrial Fibrillation 11/2002
1	Pulmonary Vein Stenosis 11/2002

Drug/Important Bio-Agent (IBA)

5	SphingolipidsIBA 06/2022 - 11/2011
5	EnzymesIBA 01/2019 - 07/2007
4	Glucosylceramidase (Glucocerebrosidase)IBA 05/2017 - 07/2007
4	CeramidesIBA 01/2017 - 07/2011
4	Acid CeramidaseIBA 05/2013 - 07/2011
2	CeramidasesIBA 04/2021 - 11/2011
2	(2R,3Z)- N- (1- hydroxyoctadec- 3- en- 2- yl)pivalamideIBA 06/2012 - 07/2011
2	Antineoplastic Agents (Antineoplastics)IBA 05/2012 - 07/2011
2	Sirolimus (Rapamycin)FDA Link 01/2007 - 09/2004
1	pachastrissamineIBA 06/2022
1	Amino Acids FDA Link 01/2022
1	AcidsIBA 04/2021
1	Alkaline CeramidaseIBA 04/2021
1	SoilIBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	NitratesIBA 01/2019
1	morpholineIBA 06/2016
1	ProdrugsIBA 06/2016
1	Phosphates (Orthophosphate)IBA 05/2016
1	SphingosineIBA 05/2016
1	ketodihydrosphingosineIBA 04/2016
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Glucosylceramides (Glucocerebrosides)IBA 01/2014
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 06/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013
1	N-caproylsphingosineIBA 06/2012
1	Pharmaceutical PreparationsIBA 06/2012
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2012
1	FenretinideIBA 07/2011
1	Hormones (Hormone)IBA 07/2011
1	retinamideIBA 07/2011
1	AmidesIBA 07/2011
1	Antipsychotic Agents (Antipsychotics)IBA 03/2011
1	SugarsIBA 10/2010
1	ferrous sulfate FDA Link 10/2010
1	IronIBA 10/2010
1	ferrous phosphateIBA 10/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2007
1	Ondansetron (Zofran)FDA LinkGeneric 02/2006
1	metopimazineIBA 02/2006
1	Dihydroergotamine (Agit)FDA LinkGeneric 01/2004
1	Mesylates (Mesylate)IBA 01/2004

Therapy/Procedure

5	Therapeutics 01/2014 - 03/2011
5	Stents 11/2005 - 11/2002
3	Drug Therapy (Chemotherapy) 11/2011 - 02/2006
1	Injections 03/2011
1	Catheters 11/2002
1	Aftercare (After-Treatment) 11/2002